A
Agilent Technologies, Inc.
Diagnostics & Research · Healthcare · United States
149.29
close · 2026-08-13
value
46
cheaper than peers46
quality
81
stronger fundamentals81
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 20.28× | 56 |
| forward P/E | 22.58× | 50 |
| price to sales | 5.41× | 46 |
| price to book | 5.92× | 44 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 23.7% | 91 |
| return on equity | 21.3% | 75 |
| debt to equity | 49.7% | 56 |
| revenue growth | 10.0% | 41 |
4 of 4 measures available
Facts
| market cap | $42B |
| free cash flow | $930.6M |
| employees | 18,000 |
| first trade | 1999-11-18 |
| next earnings | 2026-08-26 |
| fundamentals updated | 2026-07-26 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 4.57 | 4.43 | 4.19 | 4.18 |
| free cash flow | $1.15B | $1.37B | $1.47B | $1.02B |
| net income | $1.30B | $1.29B | $1.24B | $1.25B |
| revenue | $6.95B | $6.51B | $6.83B | $6.85B |